C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.49
1.43%
After-hours: Aug 15, 2025, 06:21 PM EDT

C4 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.5M 126.59M 29.75M 76.12M
Short-Term Investments
189.41M 127.09M 246.4M 233.16M
Long-Term Investments
22.36M 28.01M 60.96M 142.2M
Other Long-Term Assets
6.1M 6.17M 4.8M 3.82M
Receivables
3.1M 11.8M 1.47M 5.72M
Inventory
n/a n/a -60.96M n/a
Other Current Assets
9.76M 5.71M 9.93M 10.69M
Total Current Assets
257.77M 271.19M 287.56M 325.69M
Property-Plant & Equipment
63.38M 71.09M 77.52M 35.05M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
91.83M 105.26M 143.28M 181.08M
Total Assets
349.6M 376.45M 430.84M 506.76M
Account Payables
1.33M 1.45M 1.17M 4.51M
Deferred Revenue
18.71M 15.47M 33.51M 31.8M
Short-Term Debt
n/a n/a 6.99M 1.33M
Other Current Liabilities
9.3M 13.29M 8.24M 7.19M
Total Current Liabilities
45.18M 42.77M 44.55M 51.25M
Long-Term Debt
n/a n/a 9.2M 41.55M
Other Long-Term Liabilities
n/a n/a n/a -30.78M
Total Long-Term Liabilities
88.44M 87.57M 97.06M 65.91M
Total Liabilities
133.62M 130.34M 141.61M 117.16M
Total Debt
65.76M 70.98M 87.15M 42.88M
Common Stock
7K 6K 5K 5K
Retained Earnings
-633.7M -528.38M -395.89M -267.71M
Comprehensive Income
53K -127K -4.14M -775K
Shareholders Equity
215.99M 246.11M 289.23M 389.61M
Total Investments
211.76M 155.1M 307.36M 375.36M